Home > Cashflow Statement > AUROBINDO PHARMA

AUROBINDO PHARMA
Cash Flow from Investing Activities

    Back to Cashflow Statement
AUROBINDO PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
COMMUNITY POLL
for AUROBINDO PHARMA
Please provide your vote to see the results

AUROBINDO PHARMA Last 5 Year Cash Flow from Investing Activities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Cash Flow from Investing Activities ₹-4,256 Cr₹-3,978 Cr₹-3,212 Cr₹599 Cr₹-1,568 Cr

What is the latest Cash Flow from Investing Activities ratio of AUROBINDO PHARMA ?

The latest Cash Flow from Investing Activities ratio of AUROBINDO PHARMA is ₹-4,256 Cr based on Mar2024 Consolidated results.
Year Cash Flow from Investing Activities
Mar2024₹-4,256 Cr
Mar2023₹-3,978 Cr
Mar2022₹-3,212 Cr
Mar2021₹599 Cr
Mar2020₹-1,568 Cr

How is Cash Flow from Investing Activities of AUROBINDO PHARMA Trending?

Years Cash Flow from Investing Activities % Change
Mar2024 ₹-4,256 Cr
Negative
Mar2023 ₹-3,978 Cr
Negative
Mar2022 ₹-3,212 Cr
Negative
Mar2021 ₹599 Cr
Positive
Mar2020 ₹-1,568 Cr -

Compare Cash Flow from Investing Activities of peers of AUROBINDO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AUROBINDO PHARMA ₹72,411.2 Cr 4.9% 3.1% 11.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹441,910.0 Cr 5.4% 3.2% 20.4% Stock Analytics
DIVIS LABORATORIES ₹160,035.0 Cr 1.9% 2% 59.4% Stock Analytics
CIPLA ₹125,540.0 Cr 1.7% 2% 13.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹112,894.0 Cr 2.8% 2.3% 22.8% Stock Analytics
DR REDDYS LABORATORIES ₹100,110.0 Cr 2.1% -0.9% -1.5% Stock Analytics


AUROBINDO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
AUROBINDO PHARMA

4.9%

3.1%

11.4%

SENSEX

1%

4.3%

8.9%


You may also like the below Video Courses